169 related articles for article (PubMed ID: 7743502)
1. Transforming growth factor beta isoform-specific differences in interactions with type I and II transforming growth factor beta receptors.
Zhou GH; Sechrist GL; Periyasamy S; Brattain MG; Mulder KM
Cancer Res; 1995 May; 55(10):2056-62. PubMed ID: 7743502
[TBL] [Abstract][Full Text] [Related]
2. Clonal heterogeneity of the sensitivity of human colon carcinoma cell lines to TGE beta isoforms.
Zhou GH; Sechrist GL; Brattain MG; Mulder KM
J Cell Physiol; 1995 Dec; 165(3):512-20. PubMed ID: 7593230
[TBL] [Abstract][Full Text] [Related]
3. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta.
Chakrabarty S; Jan Y; Brattain MG; Tobon A; Varani J
Cancer Res; 1989 Apr; 49(8):2112-7. PubMed ID: 2539253
[TBL] [Abstract][Full Text] [Related]
4. Differential control of expression of type I and type II receptors of transforming growth factor-beta in colon carcinoma cells.
Periyasamy S; Sun L; Gentry LE; Brattain MG
J Cell Physiol; 1996 Sep; 168(3):711-20. PubMed ID: 8816926
[TBL] [Abstract][Full Text] [Related]
5. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
[TBL] [Abstract][Full Text] [Related]
6. Regulation of transforming growth factor beta receptors in H-ras oncogene-transformed rat intestinal epithelial cells.
Zhao J; Buick RN
Cancer Res; 1995 Dec; 55(24):6181-8. PubMed ID: 8521411
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of transforming growth factor beta 1 on mitogenic response, transforming growth factor alpha, and c-myc in quiescent, well-differentiated colon carcinoma cells.
Mulder KM; Zhong Q; Choi HG; Humphrey LE; Brattain MG
Cancer Res; 1990 Dec; 50(23):7581-6. PubMed ID: 1701348
[TBL] [Abstract][Full Text] [Related]
8. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.
Ko Y; Banerji SS; Liu Y; Li W; Liang J; Soule HD; Pauley RJ; Willson JK; Zborowska E; Brattain MG
J Cell Physiol; 1998 Aug; 176(2):424-34. PubMed ID: 9648930
[TBL] [Abstract][Full Text] [Related]
9. Evidence for c-myc in the signaling pathway for TGF-beta in well-differentiated human colon carcinoma cells.
Mulder KM; Humphrey LE; Choi HG; Childress-Fields KE; Brattain MG
J Cell Physiol; 1990 Dec; 145(3):501-7. PubMed ID: 2273056
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
11. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells.
Kumar A; Rogers T; Maizel A; Sharma S
J Immunol; 1991 Aug; 147(3):998-1006. PubMed ID: 1713611
[TBL] [Abstract][Full Text] [Related]
12. Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line.
Mulder KM; Ramey MK; Hoosein NM; Levine AE; Hinshaw XH; Brattain DE; Brattain MG
Cancer Res; 1988 Dec; 48(24 Pt 1):7120-5. PubMed ID: 3191488
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition of transforming growth factor beta on human gastric carcinoma cells: receptor and postreceptor signaling.
Ito M; Yasui W; Kyo E; Yokozaki H; Nakayama H; Ito H; Tahara E
Cancer Res; 1992 Jan; 52(2):295-300. PubMed ID: 1309437
[TBL] [Abstract][Full Text] [Related]
14. Expression of transforming growth factor beta ligand and receptor messenger RNAs in lung cancer cell lines.
Jakowlew SB; Mathias A; Chung P; Moody TW
Cell Growth Differ; 1995 Apr; 6(4):465-76. PubMed ID: 7794814
[TBL] [Abstract][Full Text] [Related]
15. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
Fralix KD; Zhao S; Venkatasubbarao K; Freeman JW
J Cell Physiol; 2003 Jan; 194(1):88-99. PubMed ID: 12447993
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.
Paterson IC; Matthews JB; Huntley S; Robinson CM; Fahey M; Parkinson EK; Prime SS
J Pathol; 2001 Apr; 193(4):458-67. PubMed ID: 11276004
[TBL] [Abstract][Full Text] [Related]
17. Relationship between actions of transforming growth factor (TGF)-beta and cell surface expression of its receptors in clonal osteoblastic cells.
Takeuchi Y; Fukumoto S; Matsumoto T
J Cell Physiol; 1995 Mar; 162(3):315-21. PubMed ID: 7860639
[TBL] [Abstract][Full Text] [Related]
18. Different signals mediate transforming growth factor-beta 1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells.
Franzén P; Ichijo H; Miyazono K
Exp Cell Res; 1993 Jul; 207(1):1-7. PubMed ID: 7686495
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of c-myc and transforming growth factor-alpha messenger RNA expression in poorly differentiated and well-differentiated colon carcinoma cells during the establishment of a quiescent state.
Mulder KM
Cancer Res; 1991 May; 51(9):2256-62. PubMed ID: 2015589
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta receptor expression on human skin fibroblasts: dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-beta binding proteins.
Tam BY; Philip A
J Cell Physiol; 1998 Sep; 176(3):553-64. PubMed ID: 9699508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
